Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab
暂无分享,去创建一个
V. Martinelli | R. Capra | L. Moiola | M. Clementi | N. Mancini | R. Burioni | R. Diotti | V. Caputo | N. de Rossi | F. Sangalli